High glucose level as a modifier factor in CMT1A patients (2020)
Source: Journal of the Peripheral Nervous System. Unidade: FMRP
Subjects: GLICOSE, DIABETES MELLITUS, NEUROPATIAS DIABÉTICAS, DOENÇAS HEREDITÁRIAS, FENÓTIPOS, PRÁTICA CLÍNICA
ABNT
SECCHIN, Juliana B. et al. High glucose level as a modifier factor in CMT1A patients. Journal of the Peripheral Nervous System, v. 25, n. 2, p. 132-137, 2020Tradução . . Disponível em: https://doi.org/10.1111/jns.12379. Acesso em: 05 dez. 2023.APA
Secchin, J. B., Leal, R. C. C., Lourenço, C. M., Marques, V. D., Nogueira, P. T. L., Santos, A. C. J., et al. (2020). High glucose level as a modifier factor in CMT1A patients. Journal of the Peripheral Nervous System, 25( 2), 132-137. doi:10.1111/jns.12379NLM
Secchin JB, Leal RCC, Lourenço CM, Marques VD, Nogueira PTL, Santos ACJ, Tomaselli PJ, Marques Júnior W. High glucose level as a modifier factor in CMT1A patients [Internet]. Journal of the Peripheral Nervous System. 2020 ; 25( 2): 132-137.[citado 2023 dez. 05 ] Available from: https://doi.org/10.1111/jns.12379Vancouver
Secchin JB, Leal RCC, Lourenço CM, Marques VD, Nogueira PTL, Santos ACJ, Tomaselli PJ, Marques Júnior W. High glucose level as a modifier factor in CMT1A patients [Internet]. Journal of the Peripheral Nervous System. 2020 ; 25( 2): 132-137.[citado 2023 dez. 05 ] Available from: https://doi.org/10.1111/jns.12379